Louis Luttrell to Drug Design
This is a "connection" page, showing publications Louis Luttrell has written about Drug Design.
Connection Strength
1.055
-
Brave new world? Arrestin pathway bias in drug design. Endocr Metab Immune Disord Drug Targets. 2011 Jun; 11(2):90-1.
Score: 0.348
-
Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. Methods Mol Biol. 2011; 756:3-35.
Score: 0.338
-
Translating in vitro ligand bias into in vivo efficacy. Cell Signal. 2018 01; 41:46-55.
Score: 0.131
-
Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol. 2013; 522:229-62.
Score: 0.097
-
Preface. The molecular biology of arrestins. Prog Mol Biol Transl Sci. 2013; 118:xv.
Score: 0.097
-
Functional signaling biases in G protein-coupled receptors: Game Theory and receptor dynamics. Mini Rev Med Chem. 2012 Aug; 12(9):831-40.
Score: 0.024
-
Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther. 2009 Nov; 331(2):340-8.
Score: 0.019